Neuronetics, Inc. (NASDAQ: STIM) is a medical device company developing and commercializing non-invasive neuromodulation therapies for the treatment of psychiatric and neurological disorders. Founded in 2003 and headquartered in Malvern, Pennsylvania, Neuronetics is the pioneer in Repetitive Transcranial Magnetic Stimulation (rTMS) technology for major depressive disorder (MDD)[1].
The company flagship product, the NeuroStar Advanced Therapy system, is an FDA-cleared TMS device used by psychiatrists and neurologists to treat patients with major depressive disorder who have not responded to antidepressant medications[2].
NeuroStar is a comprehensive TMS system:
| Component | Description |
|---|---|
| Treatment Coil | Figure-8 coil for targeted stimulation |
| Treatment Chair | Ergonomic patient positioning |
| Control System | Integrated software and hardware |
| Navigation | SmartCoil technology for targeting |
| Reporting | Treatment tracking and analytics |
| Indication | Clearance Year |
|---|---|
| Major Depressive Disorder | 2008 |
| Chronic pain | 2018 |
| OCD | 2022 |
| Adolescent MDD | 2024 |
NeuroStar has extensive clinical trial data:
| Study | Patients | Results |
|---|---|---|
| SMART | 307 MDD patients | 58% remission rate |
| THREE | 229 treatment-resistant | Significant improvement |
| FORWARD | 409 patients | Durable response at 12 months |
NeuroStar delivers magnetic pulses to the left prefrontal cortex:
Major Depressive Disorder (MDD)
| Condition | Evidence Level |
|---|---|
| Bipolar depression | Emerging |
| PTSD | Growing |
| Chronic pain | Preliminary |
| Parkinson depression | Preliminary |
| Company | Product | Technology | Market |
|---|---|---|---|
| Neuronetics | NeuroStar | rTMS 10Hz | Leader |
| Magstim | Rapid2 | rTMS | Significant |
| Brainsway | Deep TMS | Deep TMS | Growing |
| Nexstim | eSmart | Navigated TMS | Niche |
| Feature | NeuroStar Advantage |
|---|---|
| FDA history | First cleared TMS device |
| Clinical data | Extensive RCT evidence |
| Treatment network | Over 1,000 treatment centers |
| Reimbursement | Established CPT codes |
Malvern, Pennsylvania, USA
Neuronetics Inc. Neuronetics Corporate Overview. 2024. ↩︎
U.S. Food and Drug Administration. NeuroStar Advanced Therapy System 510(k) Clearance. 2008. ↩︎